Clinigen

Clinigen company information, Employees & Contact Information

Updated May 2026

Quick answer

Clinigen is a Pharmaceutical Manufacturing company and founded in 2010. It has approximately 599 employees on record. Contact data was last refreshed in May 2026. Find Clinigen's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

Our mission is to accelerate access to medicines for patients in every corner of the globe: Clinical Services, Product Access and Commercialisation, Pharmacovigilance and Regulatory Affairs.

Company Details

Employees
599
Founded
-
Address
25 Bedford Square, Bloomsbury,united Kingdom
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
London, England
Looking for a particular Clinigen employee's phone or email?

Clinigen Questions

News

MaaT Pharma Announces Exclusive Commercialization Partnership With Clinigen for Xervyteg - Business Wire

MaaT Pharma Announces Exclusive Commercialization Partnership With Clinigen for Xervyteg Business Wire

Essential Pharma and Clinigen Expand Collaboration to Improve Patient Access in JAPAC - GlobeNewswire

Essential Pharma and Clinigen Expand Collaboration to Improve Patient Access in JAPAC GlobeNewswire

Amulet Capital Sells SSI Strategy To Clinigen - citybiz

Amulet Capital Sells SSI Strategy To Clinigen citybiz

Scoop: Clinigen acquiring SSI Strategy for high-teens multiple - Axios

Scoop: Clinigen acquiring SSI Strategy for high-teens multiple Axios

Clinigen Appoints Nihad Hasagic as SVP, Clinigen Lifecycle Services - Contract Pharma

Clinigen Appoints Nihad Hasagic as SVP, Clinigen Lifecycle Services Contract Pharma

Clinigen announces executive appointments to drive growth and investor value - Pharmafile

Clinigen announces executive appointments to drive growth and investor value Pharmafile

Secura Bio Announces European Distribution Agreement for COPIKTRA® with Clinigen Healthcare Limited - PR Newswire

Secura Bio Announces European Distribution Agreement for COPIKTRA® with Clinigen Healthcare Limited PR Newswire

White & Case Advises Triton on £1.2 Billion Recommended Takeover of Clinigen Group plc - White & Case LLP

White & Case Advises Triton on £1.2 Billion Recommended Takeover of Clinigen Group plc White & Case LLP

Clinigen clears out cancer therapies in line with latest growth strategy - Pharmaceutical Technology

Clinigen clears out cancer therapies in line with latest growth strategy Pharmaceutical Technology

Clinigen snaps up Kinesys Consulting to boost regulatory offering - Fierce Pharma

Clinigen snaps up Kinesys Consulting to boost regulatory offering Fierce Pharma

Clinigen to Acquire SSI Strategy - Triton Partners

Clinigen to Acquire SSI Strategy Triton Partners

What Does Clinigen Group's (LON:CLIN) CEO Pay Reveal? - Yahoo Finance

What Does Clinigen Group's (LON:CLIN) CEO Pay Reveal? Yahoo Finance

Triton Strikes £1.2 Billion Deal for U.K. Pharma Group Clinigen - Bloomberg.com

Triton Strikes £1.2 Billion Deal for U.K. Pharma Group Clinigen Bloomberg.com

Clinigen strengthens global ethical access lead with new Japanese buy - Fierce Biotech

Clinigen strengthens global ethical access lead with new Japanese buy Fierce Biotech

Clinigen launches NaviGATE: an educational programme for rare disease patients and organisations - GlobeNewswire

Clinigen launches NaviGATE: an educational programme for rare disease patients and organisations GlobeNewswire

Triton Sweetens Clinigen (CLIN:LN) Bid to Persuade Biggest Investors - Bloomberg.com

Triton Sweetens Clinigen (CLIN:LN) Bid to Persuade Biggest Investors Bloomberg.com

Clinigen to offer Eisai’s Halaven, Fycompa and Lenvima in 10 African countries - Fierce Biotech

Clinigen to offer Eisai’s Halaven, Fycompa and Lenvima in 10 African countries Fierce Biotech

Clinigen divests global rights to four cancer support therapies to CNX Therapeutics - GlobeNewswire

Clinigen divests global rights to four cancer support therapies to CNX Therapeutics GlobeNewswire

Clinigen divests Proleukin® to Iovance Biotherapeutics for £166.7 million - GlobeNewswire

Clinigen divests Proleukin® to Iovance Biotherapeutics for £166.7 million GlobeNewswire

Clinigen Launches Malaysia Office to Strengthen Presence in Southeast Asia - Business Wire

Clinigen Launches Malaysia Office to Strengthen Presence in Southeast Asia Business Wire

Clinigen’s role in global specialty pharmaceuticals - News-Medical

Clinigen’s role in global specialty pharmaceuticals News-Medical

CNX acquires four cancer drugs from Clinigen - PharmaTimes

CNX acquires four cancer drugs from Clinigen PharmaTimes

Santhera partners with Clinigen to expand Agamree access - The Pharma Letter

Santhera partners with Clinigen to expand Agamree access The Pharma Letter

Clinigen splashes £150M for unlicensed medicines company Quantum Pharma - Fierce Biotech

Clinigen splashes £150M for unlicensed medicines company Quantum Pharma Fierce Biotech

Clinigen, Tepsivo Partner for AI-Powered Pharmacovigilance Solutions - Contract Pharma

Clinigen, Tepsivo Partner for AI-Powered Pharmacovigilance Solutions Contract Pharma

Clinigen Group : Quotes, Address, Contact - News-Medical

Clinigen Group : Quotes, Address, Contact News-Medical

Clinigen makes 3 exclusive compassionate-use deals - Fierce Biotech

Clinigen makes 3 exclusive compassionate-use deals Fierce Biotech

Nordic Pharma and Clinigen sign global Trasylol supply deal - Fierce Biotech

Nordic Pharma and Clinigen sign global Trasylol supply deal Fierce Biotech

Clinigen buys Novartis’ cancer drug Proleukin, eyes new combos - Fierce Biotech

Clinigen buys Novartis’ cancer drug Proleukin, eyes new combos Fierce Biotech

Clinigen announces acquisition of Cardioxane from Novartis - News-Medical

Clinigen announces acquisition of Cardioxane from Novartis News-Medical

Clinigen to run managed access program for Onxeo’s belinostat in Europe - Fierce Biotech

Clinigen to run managed access program for Onxeo’s belinostat in Europe Fierce Biotech

Clinigen Group To Acquire U.S. Rights to Proleukin From Novartis - BioSpace

Clinigen Group To Acquire U.S. Rights to Proleukin From Novartis BioSpace

FDA approves Clinigen’s Foscavir sNDA to treat HIV/AIDS-related CMV infections and herpes - News-Medical

FDA approves Clinigen’s Foscavir sNDA to treat HIV/AIDS-related CMV infections and herpes News-Medical

Clinigen agrees to £1.2bn takeover by Triton - Private Equity News

Clinigen agrees to £1.2bn takeover by Triton Private Equity News

Recommended Cash Acquisition of Clinigen Group plc - Triton Partners

Recommended Cash Acquisition of Clinigen Group plc Triton Partners

UK: Triton-backed Clinigen acquires SSI Strategy from Amulet Capital - Investors in Healthcare

UK: Triton-backed Clinigen acquires SSI Strategy from Amulet Capital Investors in Healthcare

Imukin deal continues acquisitive streak for Clinigen - The Pharma Letter

Imukin deal continues acquisitive streak for Clinigen The Pharma Letter

Quantum Pharma confirms Clinigen takeover bid - PMLiVE

Quantum Pharma confirms Clinigen takeover bid PMLiVE

Clinigen Group’s £225m acquisition of Idis supported by £106m in funding from Santander, RBS and HSBC - Hospital Pharmacy Europe

Clinigen Group’s £225m acquisition of Idis supported by £106m in funding from Santander, RBS and HSBC Hospital Pharmacy Europe

Private equity swoops again with Triton’s £1bn Clinigen takeover - The Times

Private equity swoops again with Triton’s £1bn Clinigen takeover The Times

Clinigen acquires Idis for £225m - PMLiVE

Clinigen acquires Idis for £225m PMLiVE

Activist Elliott floats break-up of pharma services group Clinigen - Sky News

Activist Elliott floats break-up of pharma services group Clinigen Sky News

Eisai & Clinigen to bring breast cancer drug to South Africa - Pharmafile

Eisai & Clinigen to bring breast cancer drug to South Africa Pharmafile

Clinigen Group Plc Acquires Quantum Pharma Plc - BDO UK

Clinigen Group Plc Acquires Quantum Pharma Plc BDO UK

Clinigen Group Plc acquires IDIS Group Holdings for £225m - BDO UK

Clinigen Group Plc acquires IDIS Group Holdings for £225m BDO UK

Dominic Atkins joins Clinigen GAP in senior commercial role - Pharmafile

Dominic Atkins joins Clinigen GAP in senior commercial role Pharmafile

Clinigen strengthens presence in Southeast Asia - The Vibes

Clinigen strengthens presence in Southeast Asia The Vibes

Burton drugs company Clinigen sold for £1.2billion - Stoke on Trent Live

Burton drugs company Clinigen sold for £1.2billion Stoke on Trent Live

Clinigen Group Plc Share Price | LON: CLINC Stock - Investing.com UK

Clinigen Group Plc Share Price | LON: CLINC Stock Investing.com UK

Top Clinigen Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant